08048035968
Afanat 20 mg Tablet UK Wholesale – London | Competitive Prices | Phoenix Exim | Trusted Exporter

1. General Information

Afanat 20 mg Tablet is an oral anticancer medicine containing Afatinib Dimaleate equivalent to Afatinib 20 mg. It belongs to a group of targeted cancer medicines known as tyrosine kinase inhibitors (TKIs). Afanat is primarily prescribed for adults with certain types of EGFR-mutated non-small cell lung cancer (NSCLC).

Afanat 20 mg is a prescription medicine and should be used only under the supervision of a qualified oncologist. The appropriate strength and treatment duration depend on the patient's cancer type, EGFR mutation status, overall health and tolerance to treatment.

Phoenix Exim supplies pharmaceutical products from Nagpur, India, with international sourcing and export support for eligible markets.

2. Product Information

  • Brand: Afanat 20 mg Tablet
  • Active ingredient: Afatinib Dimaleate
  • Strength: 20 mg
  • Dosage form: Oral tablet
  • Drug class: Tyrosine kinase inhibitor (TKI)
  • Primary therapeutic area: Oncology
  • Main indication: Certain EGFR-mutated non-small cell lung cancer
  • Typical pack: 28 tablets
  • Prescription: Required
  • Storage: Store below 30°C, according to the product information.
  • Marketer: Natco Pharma Ltd.

3. Uses of Afanat 20 mg Tablet

Afanat 20 mg is used for the treatment of non-small cell lung cancer (NSCLC) in adult patients whose tumors have particular activating EGFR mutations. Afatinib is a targeted treatment, so appropriate molecular testing is generally important before treatment selection.

It may be prescribed as part of an individualized cancer-treatment plan determined by an oncologist.

4. Benefits of Afanat 20 mg Tablet

The potential benefits of Afatinib include:

  • Provides targeted treatment for certain EGFR-mutated NSCLC.
  • Helps block growth signals involved in cancer-cell proliferation.
  • May help slow cancer progression in appropriately selected patients.
  • Provides an oral treatment option rather than an injectable formulation.
  • Can be incorporated into a personalized oncology treatment plan.

The benefits vary between patients and depend on the specific EGFR mutation, disease stage and response to treatment.

5. Side Effects of Afanat 20 mg Tablet

Afatinib can cause side effects, and some may require medical attention.

Potential adverse effects include:

  • Diarrhea
  • Skin rash
  • Dry skin
  • Nausea
  • Reduced appetite
  • Mouth inflammation or sores
  • Vomiting
  • Acne-like skin reactions
  • Nail or skin inflammation

Diarrhea can occasionally become serious and may lead to dehydration. Patients should inform their healthcare professional if diarrhea is severe, persistent or accompanied by signs of dehydration.

6. Common Side Effects

The commonly reported side effects of Afanat 20 mg include:

Diarrhea, rash, dry skin and nausea.

Other reactions may occur depending on the individual patient. Do not stop or change the medicine without consulting the treating doctor.

7. How to Use Afanat 20 mg Tablet

Afanat should be taken exactly as prescribed by the oncologist.

General administration guidance includes:

  1. Take the tablet orally with water.
  2. It is generally taken on an empty stomach.
  3. Try to take it at approximately the same time each day.
  4. Swallow the tablet whole unless your healthcare professional provides different instructions.
  5. Do not take a higher or lower dose than prescribed.
  6. If you miss a dose, follow your doctor's or pharmacist's instructions rather than taking an extra dose.

The appropriate dose may be modified by the treating doctor depending on response and adverse effects.

8. How Afanat 20 mg Works

Afatinib is a tyrosine kinase inhibitor that irreversibly blocks signaling from members of the ErbB receptor family, including EGFR.

In certain lung cancers, abnormal EGFR signaling can promote cancer-cell growth and survival. By inhibiting these signaling pathways, afatinib can interfere with signals that support tumor-cell proliferation.

This targeted mechanism is why testing for relevant EGFR alterations is important when determining whether afatinib is an appropriate treatment.

9. Safety Advice for Afanat 20 mg

Prescription use only: Afanat should be used under specialist medical supervision.

Diarrhea: Report severe or persistent diarrhea promptly because significant fluid loss can cause dehydration.

Skin reactions: Use appropriate skin protection and inform your doctor about severe rash, blistering or significant skin problems.

Eye problems: Report significant eye pain, redness, visual changes or persistent eye irritation.

Liver problems: Patients with liver disease should inform their doctor before treatment. Medical monitoring may be required.

Lung symptoms: New or worsening breathing difficulties, cough or fever should be reported urgently because serious lung inflammation can occur rarely.

Pregnancy: Afatinib can potentially harm an unborn baby. Discuss pregnancy and contraception requirements with the treating doctor.

Breastfeeding: Patients should discuss breastfeeding with their healthcare professional before starting treatment.

Drug interactions: Tell your doctor about all prescription medicines, non-prescription medicines, vitamins and supplements being taken.

Do not self-medicate: Afanat is a prescription oncology medicine and should not be started, stopped or dose-adjusted without medical advice.

10. Frequently Asked Questions (FAQs)

What is Afanat 20 mg Tablet?

Afanat 20 mg is an anticancer tablet containing afatinib dimaleate 20 mg, primarily used for certain EGFR-mutated cases of NSCLC.

1.What is Afanat 20 mg used for?

It is used to treat certain forms of EGFR-mutated non-small cell lung cancer in adults.

2.Is Afanat 20 mg a chemotherapy medicine?

Afatinib is generally classified as a targeted tyrosine kinase inhibitor, rather than traditional cytotoxic chemotherapy.

3.Should Afanat 20 mg be taken with food?

Product information indicates that Afanat should generally be taken on an empty stomach. Follow the specific instructions provided by the treating physician.

4.What are the most common side effects?

Diarrhea, rash, dry skin and nausea are among the commonly reported adverse effects.

5.Can I stop Afanat if I feel better?

No. Cancer treatment should not be discontinued without consultation with the treating oncologist.

6.Is Afanat 20 mg available in different strengths?

Afanat is listed in strengths including 20 mg, 30 mg and 40 mg. The appropriate strength should be selected by the treating physician.

7.Does Afanat require a prescription?

Yes. It is a prescription oncology medicine.

8.How should Afanat be stored?

The product information indicates storage below 30°C. Keep the medicine in its original packaging and away from excessive heat and moisture.


11. Substitute for Afanat 20 mg Tablet

A substitute should contain the same active ingredient and strength and should only be selected after consultation with a healthcare professional.

Examples of afatinib products include:

  • Xovoltib 20 mg Tablet
  • Other approved Afatinib 20 mg formulations

Xovoltib 20 mg is listed as a same-composition alternative to Afatin 20 mg in Indian medicine listings.

Brand availability differs between countries, so buyers should verify the registered product, manufacturer, strength and regulatory status in the destination market.

12. SEO & B2B Keywords

Primary Keywords

  • Afanat 20 mg Tablet
  • Afanat 20 mg
  • Afatinib 20 mg Tablet
  • Afatinib Dimaleate 20 mg
  • Afatinib 20 mg supplier
  • Afatinib 20 mg exporter
  • Afanat 20 mg exporter from India
  • Afatinib tablets manufacturer India
  • Afatinib oncology medicine supplier
  • Afatinib pharmaceutical exporter

Long-Tail B2B Keywords

  • Afanat 20 mg Tablet exporter from Nagpur India
  • Afatinib 20 mg tablets supplier from India
  • Afatinib Dimaleate 20 mg pharmaceutical exporter India
  • Afanat 20 mg oncology medicine supplier India
  • Afatinib 20 mg tablets for international pharmaceutical buyers
  • Afatinib 20 mg medicine exporter to USA
  • Afatinib 20 mg medicine exporter to UK
  • Afatinib 20 mg pharmaceutical supplier Australia
  • Afatinib 20 mg tablets supplier Singapore
  • Afatinib 20 mg exporter to Canada
  • Afatinib 20 mg pharmaceutical supplier South Korea
  • Afatinib 20 mg medicine supplier UAE
  • EGFR targeted therapy medicine exporter India
  • NSCLC targeted therapy medicine supplier India
  • Afatinib oncology pharmaceutical products India
  • Generic Afatinib 20 mg tablet supplier
  • Afatinib 20 mg international medicine supplier
  • Afatinib tablets bulk pharmaceutical supplier India
  • Afanat 20 mg wholesale pharmaceutical supplier
  • Afatinib 20 mg B2B pharmaceutical exporter

Phoenix Exim SEO Phrases

  • Phoenix Exim Afanat 20 mg Tablet exporter from Nagpur India
  • Phoenix Exim Afatinib 20 mg pharmaceutical supplier
  • Phoenix Exim oncology medicine exporter India
  • Afatinib 20 mg exporter from Nagpur Maharashtra India
  • Trusted pharmaceutical exporter for Afatinib 20 mg from India
  • Afanat 20 mg international pharmaceutical supply from India
  • Afatinib 20 mg B2B medicine exporter India
  • Afatinib 20 mg supplier for USA UK Australia Canada UAE Singapore South Korea


Aug 12th, 2026 3:32 PM

Keywords